yes that add and the business model ticks the market sentiment box.
also the model does not make the merchant pay the fee, which means the fee gets passed on to the price for all consumers, because of the few.
but those 2 asx companies are in a different category of finteck. when they realise their folly they should get some wisr.
"Our base case DCF valuation is $0.131/share and rises to $0.254/share if these new revenue streams contribute as we envisage.Historical earnings and RaaS Advisory estimatesYearendRevenue(A$m)EBITDA(A$m)NPAT (A$m)EPS(c)EV/Rev(x)P/E(x)Jun-18a1.6(6.14)(6.21)(1.40)13.4n/aJun-19e6.4(0.91)(0.65)(0.13)4.3n/aJun-20e12.23.62.40.452.9 11.8 Jun-21e19.09.46.51.202.1 4.4 Source: Company Data,RaaS Advisory"
- Forums
- ASX - By Stock
- WZR
- WZR Significantly Undervalued vs Market Leader
WZR Significantly Undervalued vs Market Leader, page-36
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WZR (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.41M |
Open | High | Low | Value | Volume |
2.6¢ | 2.7¢ | 2.5¢ | $138.4K | 5.325M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 423227 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 23198 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 750032 | 0.028 |
2 | 275337 | 0.027 |
1 | 100000 | 0.026 |
2 | 113413 | 0.025 |
1 | 40000 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 399859 | 2 |
0.030 | 2464893 | 5 |
0.031 | 300000 | 1 |
0.033 | 3257 | 1 |
0.034 | 267613 | 2 |
Last trade - 15.00pm 25/11/2024 (20 minute delay) ? |
Featured News
WZR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online